A recent scientific investigation has raised concerns about the safety of the widely prescribed drug Nifedipine, commonly used to treat high blood pressure and chest pain. Researchers suggest that higher doses of this medication may be linked to an increased risk of sudden cardiac arrest. Interestingly, another drug in the same category, Amlodipine, did not show the same level of risk in the study.
Key Highlights
- High doses of Nifedipine may be associated with a greater risk of sudden cardiac arrest
- Amlodipine appears to be safer in comparison within this study
- The potential mechanism involves dangerous heart rhythm disturbances
- Findings are preliminary and require further confirmation
- No immediate changes in prescriptions are recommended without medical advice
Why This Matters
Sudden cardiac arrest is a life-threatening condition where the heart suddenly stops beating effectively. It requires immediate medical intervention and can be fatal within minutes. This condition remains a major global health issue, affecting hundreds of thousands of people each year.
The ESCAPE-NET Research
The findings come from the ESCAPE-NET project, a European research initiative focused on identifying causes and risk factors of cardiac arrest. The study analyzed data from more than 10,000 individuals using calcium channel blockers and compared them with over 50,000 control subjects.
The results showed that patients taking high doses of Nifedipine had a significantly higher risk of experiencing out-of-hospital cardiac arrest compared to those not taking the medication or those using Amlodipine.
Continue reading the full explanation and scientific insights on the next page →
